Evidence map›Paper›PMID 28874842›Full record

ArticleScientific reports2017

Investigation of Mitochondrial Metabolic Response to Doxorubicin in Prostate Cancer Cells: An NADH, FAD and Tryptophan FLIM Assay.

Shagufta Rehman Alam, Horst Wallrabe, Zdenek Svindrych, Ajay K Chaudhary, Kathryn G Christopher, Dhyan Chandra, Ammasi Periasamy

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Label-free optical biomarker for prostate cancer diagnosis.Molecular medicine (Cambridge, Mass.) · 2026
    Article
  3. Fluorescence lifetime imaging ophthalmoscopy (FLIO) of patients with neovascular age-related macular degeneration before and after treatment with intravitreal ranibizumab.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Investigating Cellular Magnetic Bioeffects Using Two-Channel, Two-Photon Autofluorescence Lifetime Microscopy.IEEE transactions on molecular, biological, and multi-scale communications · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Efficacy Evaluation of "Enhanced" Natural Killers withSovremennye tekhnologii v meditsine · 2025
    Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shagufta Rehman AlamThe W.M. Keck Center for Cellular Imaging, Physical and Life Sciences Building, University of Virginia, 90 Geldard Dr., Charlottesville, Virginia, 22904, USA.
Horst WallrabeThe W.M. Keck Center for Cellular Imaging, Physical and Life Sciences Building, University of Virginia, 90 Geldard Dr., Charlottesville, Virginia, 22904, USA.
Zdenek SvindrychThe W.M. Keck Center for Cellular Imaging, Physical and Life Sciences Building, University of Virginia, 90 Geldard Dr., Charlottesville, Virginia, 22904, USA.
Ajay K ChaudharyRoswell Park Cancer Institute, Centre for Genetics and Pharmacology, Department of Pharmacology and Therapeutics, Elm & Carlton Streets, Buffalo, New York, 14263, USA.
Kathryn G ChristopherDepartments of Biology and Biomedical Engineering, University of Virginia, 90 Geldard Dr., Charlottesville, Virginia, 22904, USA.
Dhyan ChandraRoswell Park Cancer Institute, Centre for Genetics and Pharmacology, Department of Pharmacology and Therapeutics, Elm & Carlton Streets, Buffalo, New York, 14263, USA.
Ammasi PeriasamyThe W.M. Keck Center for Cellular Imaging, Physical and Life Sciences Building, University of Virginia, 90 Geldard Dr., Charlottesville, Virginia, 22904, USA. ap3t@virginia.edu.
University of Virginia · USRoswell Park Comprehensive Cancer Center · US

Funding

Zeiss 780 NLO High Sensitivity Multiphoton Microscopy SystemS10OD016446 · OD · UNIVERSITY OF VIRGINIA · PI PERIASAMY, AMMASI · 2013 to 2013
$600k
Dual-modal Microscopy of Metabolic Reprogramming in CancerR21EB020843 · NIBIB · UNIVERSITY OF VIRGINIA · PI HU, SONG, PERIASAMY, AMMASI · 2016 to 2017
$412k
NIBIB NIH HHS R21 EB020843NIH HHS S10 OD016446
6 · The paper itself

Abstract

Prostate cancer (PCa) is one of the leading cancers in men in the USA. Lack of experimental tools that predict therapy response is one of the limitations of current therapeutic regimens. Mitochondrial dysfunctions including defective oxidative phosphorylation (OXPHOS) in cancer inhibit apoptosis by modulating ROS production and cellular signaling. Thus, correction of mitochondrial dysfunction and induction of apoptosis are promising strategies in cancer treatment. We have used Fluorescence Lifetime Imaging Microscopy (FLIM) to quantify mitochondrial metabolic response in PCa cells by tracking auto-fluorescent NAD(P)H, FAD and tryptophan (Trp) lifetimes and their enzyme-bound fractions as markers, before and after treatment with anti-cancer drug doxorubicin. A 3-channel FLIM assay and quantitative analysis of these markers for cellular metabolism show in response to doxorubicin, NAD(P)H mean fluorescence lifetime (τ

Indexed as

Antibiotics, AntineoplasticApoptosisCell Line, TumorDoxorubicinEnergy MetabolismFlavin-Adenine DinucleotideHumansMaleMicroscopy, FluorescenceMitochondriaNADPOptical ImagingOxidation-ReductionOxidative PhosphorylationOxidative StressProstatic NeoplasmsAntibiotics, AntineoplasticDoxorubicinFlavin-Adenine DinucleotideNADPReactive Oxygen SpeciesTryptophan

Identifiers

PMID28874842
PMCPMC5585313
OpenAlexW2753889698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.